METHODS FOR IMPROVED APTAMER SELECTION
Methods are provided herein for generating and selecting aptamers. The aptamers can be suitable as therapeutic aptamers for the treatment of a disease or disorder. The methods provided may improve the efficiency and/or effectiveness of generating a therapeutic aptamer over traditional methods. The methods may generally involve selective pressure including competitive elution to generate aptamers that specifically bind to therapeutically-relevant epitopes and have a desired mechanism of action.
1 . A method for selecting a desired aptamer with high affinity for a target epitope of a target molecule, said method comprising:
a. obtaining an aptamer library comprising a plurality of aptamers;
b. contacting said aptamer library with a solid support such that non-specific aptamers bind to said solid support, thereby generating an aptamer library depleted of said non-specific aptamers;
c. incubating said aptamer library depleted of said non-specific aptamers with an isolated target molecule comprising said target epitope to form an aptamer-target molecule complex by binding of at least one aptamer of said aptamer library to said target epitope;
d. incubating said aptamer-target molecule complex with a competitor capable of specifically binding to said target epitope, thereby eluting said at least one aptamer from said target epitope;
e. recovering said at least one aptamer; and
f. iteratively repeating d)-e) one or more times, thereby selecting for a desired aptamer with high affinity for a target epitope of a target molecule,
wherein said at least one aptamer binds to said target epitope with a K d of less than about 100 nM.
2 . The method of claim 1 , further comprising, prior to said incubating of c), immobilizing said target molecule to a solid support.
3 .- 9 . (canceled)
10 . A method for selecting for a desired aptamer that specifically binds to a target epitope with high affinity, said method comprising:
a. obtaining an aptamer library;
b. incubating said aptamer library with a target molecule comprising said target epitope to form an aptamer-target molecule complex by at least one aptamer binding to said target epitope;
c. incubating a competitor, capable of specifically binding to said target epitope, with said aptamer-target molecule complex at a ratio of at least 1000:1, thereby eluting said at least one aptamer from said target epitope; and
d. recovering said at least one aptamer, thereby selecting for a desired aptamer that specifically binds to a target epitope with high affinity.
11 . The method of claim 10 , further comprising, prior to b), immobilizing said target molecule to a solid support.
12 . The method of claim 11 , further comprising, prior to b),
contacting said aptamer library with a solid support in the absence of said target molecule to remove non-specific aptamers.
13 . The method of claim 10 , wherein c) further comprises providing said competitor at a high molar excess relative to said aptamer-target molecule complex.
14 . The method of claim 13 , further comprising performing two or more iterative rounds of c).
15 . The method of claim 10 , further comprising, repeating a)-d) one or more times, each time with a successively greater amount of competitor in c).
16 . The method of claim 10 , further comprising, prior to b), depleting non-target epitope binding aptamers from said aptamer library, comprising: i) incubating said target molecule with said competitor such that said competitor binds to said target epitope on said target molecule to generate a competitor-target molecule complex; ii) incubating said competitor-target molecule complex with said aptamer library such that non-target epitope binding aptamers bind to said competitor-target molecule complex and target epitope-binding aptamers do not bind to said competitor-target molecule complex; iii) collecting said target epitope-binding aptamers, thereby depleting non-target epitope binding aptamers from said aptamer library.
17 . The method of claim 10 , further comprising repeating c) one or more times in an iterative fashion.
18 . The method of claim 17 , wherein said repeating comprises incubating said aptamer-target molecule complex with successively greater amounts of competitor.
19 . The method of claim 17 , wherein said repeating comprises incubating said aptamer-target molecule complex with different competitors.
20 .- 23 . (canceled)
24 . A method of selecting for a desired aptamer that specifically binds to a target epitope on a target molecule with high affinity, the method comprising:
a. incubating target molecules comprising said target epitope with a non-competitive binder that blocks some, but not all, of said target epitopes on said target molecules;
b. obtaining an aptamer library comprising a number of aptamers capable of binding to said target epitope, wherein said number of aptamers capable of binding to said target epitope is greater than the number of unblocked epitopes and said number of aptamers have different binding affinities for said target epitope;
c. incubating said target molecules comprising blocked and unblocked target epitopes with said aptamer library such that said number of aptamers compete for binding to an unblocked target epitope, wherein an aptamer of said number of aptamers with higher affinity for said target epitope binds said target epitope and an aptamer of said number of aptamers with lower affinity for said target epitope does not bind said target epitope, thereby selecting for a desired aptamer that specifically binds to a target epitope with high affinity.
25 . (canceled)
26 . (canceled)
27 . The method of claim 10 , wherein said competitor is an antibody or antibody fragment thereof, a small molecule or a peptide.
28 . The method of claim 10 , wherein said competitor is a monoclonal antibody.
29 .- 32 . (canceled)
33 . The method of claim 10 , wherein said desired aptamer binds to said target molecule with a K d of about 100 nM or less.
34 .- 37 . (canceled)
38 . The method of claim 10 , wherein said competitor is a therapeutic molecule used for the treatment of a target disease.
39 . The method of claim 10 , wherein said aptamer library comprises at least 10 14 different aptamer sequences.
40 . The method of claim 10 , wherein said competitor is incubated with said aptamer-target molecule complex at a high molar excess.
41 . (canceled)
42 . The method of claim 10 , wherein said target molecule is a recombinant protein or peptide.
43 . The method of claim 10 , wherein said aptamer library is a DNA aptamer library, a modified DNA aptamer library, an RNA aptamer library, or a modified RNA aptamer library.
44 . (canceled)
45 . (canceled)